Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.797109
Title: Induction of immunological tolerence to kidney allografts following donor-specific blood transfusion : experimental studies in the rat
Author: Tweedle, James R.
Awarding Body: University of Glasgow
Current Institution: University of Glasgow
Date of Award: 1997
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Donor-specific blood transfusion (DSBT) prior to renal transplantation has been known to have a beneficial effect on graft survival for over twenty years. In experimental models the magnitude of this effect is markedly strain-dependent. Two principal MHC disparate rat strain combinations were used to examine possible mechanisms of DSBT induced tolerance of renal allografts in this study. The first of these was an established model where a single pretransplant blood transfusion produces tolerance (DA into PVG: fully MHC disparate). The second (R8 into RT1u: class I-disparate) involved the development of a new model where DSBT alone was ineffective but the addition of a short course of cyclosporin A (15mg/kg/day for 7 days) at the time of the first of 4 weekly blood transfusions induced tolerance. In the first model, DA into PVG, over 80% of animals showed long-term acceptance of a kidney allograft following a single I ml DSBT 7 days prior to transplant. The tolerance was not tissue-specific and was independent of the thymus gland. Graft adaptation was seen in this model as passenger leukocyte depleted grafts survived for approximately 100 days in unmodified hosts (normal rejection time < 10 days). Cytokine levels present in rejecting, enhanced and syngeneic grafts were examined by semi-quantitative PCR. Levels of IFN-gamma, IL-4 and IL-10 were broadly similar in rejecting and enhanced grafts but the peak in IL-2 message around 4 days following transplant in the rejecting grafts was abrogated in the enhanced grafts. In the second model, R8 into RT1U, tolerance was again achieved in >80% of animals and was independent of the thymus gland. No evidence was seen for graft adaptation. Graft acceptance following DSBT/cyclosporin A-pretreatment correlated with low levels of cytotoxic alloantibody while DSBT alone led to high alloantibody levels and graft rejection. Interestingly the production of intragraft Th2 cytokines correlated with graft rejection rather than tolerance. This observation may reflect the immunological role of alloantibody in causing graft damage in this experimental model whereas in other models alloantibody may tend to favour tolerance rather than rejection. This protocol for tolerance induction was also shown to be effective in a fully disparate strain combination (DA into Lewis) where it was found that increasing the number of transfusions improved graft survival. Both of these models suggest that DSBT-pretreatments have a potential role in clinical practice especially when cyclosporin A is likely to be used as the principle immunosuppressant. DSBT is currently used in a small number of transplant centres but a greater understanding of the underlying mechanisms and development of a more effective protocol is required if its use is to become widespread.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (M.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.797109  DOI: Not available
Share: